swisspartners Ltd. - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 34 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
swisspartners Ltd. ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$97,465
-43.7%
110,0000.0%0.12%
-30.7%
Q3 2022$173,000
-24.1%
110,0000.0%0.18%
-17.9%
Q2 2022$228,000
-10.9%
110,0000.0%0.22%
+7.4%
Q1 2022$256,000
-50.6%
110,0000.0%0.20%
-44.7%
Q4 2021$518,000
-38.3%
110,0000.0%0.37%
-43.5%
Q3 2021$839,000
-21.3%
110,0000.0%0.65%
-14.1%
Q2 2021$1,066,000
+17.0%
110,0000.0%0.76%
+2.3%
Q1 2021$911,000110,0000.74%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders